Literature DB >> 15501396

Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients.

Miyako Okamoto1, Yasushi Ogawa, Akihiro Watanabe, Kazumitsu Sugiura, Yutaka Shimomura, Noriaki Aoki, Tetsuro Nagasaka, Yasushi Tomita, Yoshinao Muro.   

Abstract

Alopecia areata (AA) has been suspected to be an autoimmune disease, although there is no distinct evidence, we investigated the relationship between AA and autoantibodies against dense fine speckles 70 kDa (DFS70) in 111 patients with alopecia and 105 healthy controls. The sera from 59 out of 111 (53%) Japanese alopecia patients were positive for anti-nuclear antibody (ANA), as compared to the sera of 16 out of 105 (15%) healthy controls (p < 0.001). Twenty percent (22/111) of the alopecia patients were shown to be positive for the prevalence of anti-DFS70 antibodies, as compared to 8% (8/105) of the healthy controls (p < 0.01). IgG subclass analysis by ELISA showed that IgG1 and IgG2-anti-DFS70 antibodies were dominant in alopecia patients. The DFS70 gene expression in the hair structures was clearly detected in both those with and those without the anti-DFS70 antibody by RT-PCR. Immunohistochemical techniques showed that the DFS70 was localized predominantly in the outer root sheath (ORS) cells. The elevated anti-DFS70 antibodies in alopecia patients and the localization of the DFS70 in the ORS suggest that autoantibodies against the DFS70 are related to the etiology in a certain population of AA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501396     DOI: 10.1016/j.jaut.2004.07.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  16 in total

1.  Serum level of macrophage migration inhibitory factor (MIF) in Egyptians with alopecia areata and its relation to the clinical severity of the disease.

Authors:  Doreen Nazeih Assaad Younan; Naglaa Agamia; Adel Elshafei; Nancy Ebeid
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

Review 2.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 3.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

4.  Lens epithelium-derived growth factor deSumoylation by Sumo-specific protease-1 regulates its transcriptional activation of small heat shock protein and the cellular response.

Authors:  Keiichi Ishihara; Nigar Fatma; Biju Bhargavan; Bhavana Chhunchha; Eri Kubo; Sanjib Dey; Yoshihiro Takamura; Anil Kumar; Dhirendra P Singh
Journal:  FEBS J       Date:  2012-07-16       Impact factor: 5.542

Review 5.  [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].

Authors:  R Mierau
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

6.  Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients.

Authors:  Hassan Seyrafi; Maryam Akhiani; Hamed Abbasi; Sahar Mirpour; Ali Gholamrezanezhad
Journal:  BMC Dermatol       Date:  2005-10-31

7.  Thrombophilia Associated with Anti-DFS70 Autoantibodies.

Authors:  Julien Marlet; Annick Ankri; Jean-Luc Charuel; Pascale Ghillani-Dalbin; Amélie Perret; Isabelle Martin-Toutain; Julien Haroche; Zahir Amoura; Lucile Musset; Makoto Miyara
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

Review 8.  Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Michael Mahler; Pier-Luigi Meroni; Xavier Bossuyt; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-27       Impact factor: 4.818

Review 9.  The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.

Authors:  Robert L Ochs; Michael Mahler; Anamika Basu; Leslimar Rios-Colon; Tino W Sanchez; Luis E Andrade; Marvin J Fritzler; Carlos A Casiano
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

10.  Confirmation of anti-DFS70 antibodies is needed in routine clinical samples with DFS staining pattern.

Authors:  Esvet Mutlu; Mete Eyigör; Derya Mutlu; Meral Gültekin
Journal:  Cent Eur J Immunol       Date:  2016-03-24       Impact factor: 2.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.